Callio Therapeutics has raised $187m in Series A financing round for achieving clinical proof-of-concept for HER2-targeted ...
Callio Therapeutics, a biotechnology company, has launched with the closing of a $187.0 million Series A financing round.
South Africa's Competition Commission investigates Novo Nordisk and Sanofi for potential anti-competitive practices in the insulin pen market.
Frazier Life Sciences launched Callio Therapeutics, a cancer startup headquartered in Seattle and Singapore. Frazier led ...
South Africa's competition watchdog launches a crucial investigation into pharmaceutical giants Novo Nordisk and Sanofi over ...
After a decade of being the primary supplier of human insulin pens in South Africa, Novo decided against bidding for the 2024 ...
Frazier Life Sciences launches Callio Therapeutics based on multi-payload antibody-drug conjugate technology and programs exclusively in-licensed from Singapore-based Hummingbird BioscienceFinancing ...
Biotech-focused investment firm Frazier Life Sciences has launched Callio Therapeutics, a cancer treatment startup with headquarters ... life sciences investors: Novo Holdings A/S, Omega Funds ...
South African billionaire Stephen Saad says Aspen Pharmacare is ready to leverage the ‘largest opportunity in the global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback